000108578 001__ 108578
000108578 005__ 20230519145341.0
000108578 0247_ $$2doi$$a10.1016/j.ejogrb.2020.11.069
000108578 0248_ $$2sideral$$a121266
000108578 037__ $$aART-2021-121266
000108578 041__ $$aeng
000108578 100__ $$0(orcid)0000-0001-9585-0187$$aSavirón-Cornudella, Ricardo$$uUniversidad de Zaragoza
000108578 245__ $$aSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery
000108578 260__ $$c2021
000108578 5060_ $$aAccess copy available to the general public$$fUnrestricted
000108578 5203_ $$aObjective
To screen pregnant women at risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during delivery using reverse-transcription polymerase chain reaction (RT-PCR) test and serum immunoglobulin (Ig) testing.
Method
Between March 31 st and August 31 st of 2020, consecutive pregnant women admitted for labor and delivery in a single hospital were screened for SARS-CoV-2 with nasopharyngeal RT-PCR swab tests and detection of serum IgG and IgM.
Results
We studied 266 pregnant women admitted for labor and delivery. The prevalence of acute or past SARS-CoV-2 infection was 9.0 %, including (i) two cases with respiratory symptoms of SARS-Co-V-2 infection and positive RT-PCR; (ii) four asymptomatic women with positive RT-PCR without clinical symptoms and negative serological tests between two and 15 weeks later; and (iii) two women with false positive RT-PCR due to technical problems. All newborns of the 6 pregnant women with RT-PCR positive had negative RT-PCR and did not require Neonatal Intensive Care Unit admission. There were eighteen asymptomatic women with positive serological IgG tests and negative RT-PCR.
Conclusion
In our cohort of gravids, we found 2.2 % of women with positive RT-PRC tests and 6.7 % with positive serological tests during the first wave of the SARS-CoV-2 pandemic.
000108578 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc-nd$$uhttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
000108578 590__ $$a2.831$$b2021
000108578 592__ $$a0.635$$b2021
000108578 594__ $$a3.3$$b2021
000108578 591__ $$aREPRODUCTIVE BIOLOGY$$b21 / 31 = 0.677$$c2021$$dQ3$$eT3
000108578 593__ $$aReproductive Medicine$$c2021$$dQ2
000108578 591__ $$aOBSTETRICS & GYNECOLOGY$$b46 / 85 = 0.541$$c2021$$dQ3$$eT2
000108578 593__ $$aObstetrics and Gynecology$$c2021$$dQ2
000108578 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/acceptedVersion
000108578 700__ $$aVillalba, Ana
000108578 700__ $$aZapardiel, Javier
000108578 700__ $$aAndeyro-Garcia, Mercedes
000108578 700__ $$0(orcid)0000-0002-3007-302X$$aEsteban Escaño, Luis Mariano
000108578 700__ $$0(orcid)0000-0002-2801-416X$$aPérez López, Faustino Ramón
000108578 7102_ $$11003$$2027$$aUniversidad de Zaragoza$$bDpto. Anatom.Histolog.Humanas$$cArea Anatom.Embriol.Humana
000108578 773__ $$g256 (2021), 400-404$$pEur. j. obstet., gynecol., reprod. biol.$$tEuropean Journal of Obstetrics and Gynecology and Reproductive Biology$$x0301-2115
000108578 8564_ $$s635433$$uhttps://zaguan.unizar.es/record/108578/files/texto_completo.pdf$$yPostprint
000108578 8564_ $$s1597222$$uhttps://zaguan.unizar.es/record/108578/files/texto_completo.jpg?subformat=icon$$xicon$$yPostprint
000108578 909CO $$ooai:zaguan.unizar.es:108578$$particulos$$pdriver
000108578 951__ $$a2023-05-18-13:14:55
000108578 980__ $$aARTICLE